These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A transgenic mouse model of hemoglobin S Antilles disease. Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865 [TBL] [Abstract][Full Text] [Related]
4. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454 [TBL] [Abstract][Full Text] [Related]
5. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655 [TBL] [Abstract][Full Text] [Related]
6. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin. Reilly MP; Chomo MJ; Obata K; Asakura T Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846 [TBL] [Abstract][Full Text] [Related]
7. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990 [TBL] [Abstract][Full Text] [Related]
8. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia. Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593 [TBL] [Abstract][Full Text] [Related]
9. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Monplaisir N; Merault G; Poyart C; Rhoda MD; Craescu C; Vidaud M; Galacteros F; Blouquit Y; Rosa J Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9363-7. PubMed ID: 3467311 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele. Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863 [TBL] [Abstract][Full Text] [Related]
11. Towards a mouse model for sickle cell disease: HB SAD. Trudel M; Garel MC; Saadane N; Rouyer-Fessard P; Vidaud D; Costantini F; Beuzard Y Nouv Rev Fr Hematol (1978); 1990; 32(6):407-8. PubMed ID: 2101873 [TBL] [Abstract][Full Text] [Related]
12. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455 [TBL] [Abstract][Full Text] [Related]
13. Mouse alpha chains inhibit polymerization of hemoglobin induced by human beta S or beta S Antilles chains. Rhoda MD; Domenget C; Vidaud M; Bardakdjian-Michau J; Rouyer-Fessard P; Rosa J; Beuzard Y Biochim Biophys Acta; 1988 Jan; 952(2):208-12. PubMed ID: 3337825 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human hemoglobins designed for gene therapy of sickle cell disease. McCune SL; Reilly MP; Chomo MJ; Asakura T; Townes TM Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9852-6. PubMed ID: 7937904 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease. Fabry ME; Kennan RP; Paszty C; Costantini F; Rubin EM; Gore JC; Nagel RL J Clin Invest; 1996 Dec; 98(11):2450-5. PubMed ID: 8958206 [TBL] [Abstract][Full Text] [Related]
17. A transgenic mouse model of sickle cell disorder. Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310 [TBL] [Abstract][Full Text] [Related]
18. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Ye L; Chang JC; Lu R; Kan YW Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438 [TBL] [Abstract][Full Text] [Related]
19. Effect of zeta-globin substitution on the O2-transport properties of Hb S in vitro and in vivo. He Z; Russell JE Biochem Biophys Res Commun; 2004 Dec; 325(4):1376-82. PubMed ID: 15555579 [TBL] [Abstract][Full Text] [Related]
20. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease. He Z; Russell JE Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]